Replies to post #798923 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

Thank you Beartrap for your input. One thing that bothers me is that
the response I received from AI implies that the switch from manual to
the Flaskworks methodology would obviously delay the approval and is
therefore a material event that should have been PRd.

Since we never received such a PR I am assuming that the approval will
be announced well before mid year 2026 and we will start with the manual
manufacturing methodology.

Furthermore, ATL-nsider just mentioned that there is apparently no reason
that the completed B rooms cannot be utilized for the Flaskworks manufacturing
procedures (provided that some certified Flaskworks units are available).
Of course once the C suites are ready during mid 2026, DCVax-L manufacturing
will be greatly accelerated.

I may be completely wrong but that is currently my opinion.